Abiraterone Acetate 500 mg: Uses, Dosage, and Benefits
                     ABIRAKAST – 
ABIRATERONE 
ACETATE 
TABLETS IP 500 
MMecGhanism, Uses, Dosage, 
and Safety
INTRODUCTION TO 
ABIRAKAST
• Abirakast is a method of Abiraterone 
Acetate 500 mg, used for treating 
prostate most cancers
• Manufactured through Aprazer 
Healthcare
• Used with prednisone for metastatic 
castration-resistant prostate cancer 
(mCRPC)
• Abirakast inhibits CYP17 enzyme, 
MECHANIS decreasing androgen (testosterone) production
• Targets testes, adrenal glands, 
M OF and prostate tumor cells• Reduces tumor growth with the 
ACTION aid of lowering testosterone degrees
INDICATIONS:
• mCRPC (metastatic castration-
resistant prostate cancer)
• MCSPC (metastatic castration-
sensitive prostate most cancers)
INDICATION
S & DOSAGE:
• 500 mg as soon as daily (1 pill in line 
DOSAGE with day)• Taken on an empty belly• Must be used with prednisone (5 mg 
two times every day)
SIDE EFFECTS 
& 
P• CRommEon CSide Effects:• Fatigue, joint ApainU, excTessiIveO blooNd strSess, nausea
• Serious Risks:
• Liver toxicity, adrenal insufficiency, low potassium
• Precautions:
• Regular liver feature tests, blood stress tracking 
required
CLINICAL 
EFFICACY & 
•RProEvenS effEectiAvenRess Cin mHCRPC & mCSPC 
treatment
• Key Clinical Trials:
• LATITUDE Study – Improved survival in 
newly recognized metastatic prostate 
most cancers
• COU-AA-302 Study – Significant survival 
advantages for chemotherapy-naïve 
mCRPC sufferers
• Often blended with androgen deprivation 
remedy (ADT)
CONCLUSION & 
KEY TAKEAWAYS
• Abirakast 500 mg is an powerful treatment for advanced 
prostate cancer
• Used with prednisone to decorate effectiveness and reduce 
side outcomes
• Requires habitual tracking for protection
• Ongoing research aims to extend its use in early-stage 
prostate cancer
Visit at: https://galaxysuperspeciality.Com/product/abirakast-abiraterone-acetate-tablets-ip-500-mg/